These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation. Russell CA. Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093 [Abstract] [Full Text] [Related]
11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J. Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [Abstract] [Full Text] [Related]
12. Communication with patients and their families, who undergo bone marrow transplantation. Krasuska ME, Stanisławek A. Ann Univ Mariae Curie Sklodowska Med; 2003 Apr; 58(2):168-73. PubMed ID: 15323187 [Abstract] [Full Text] [Related]
14. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ. Bone Marrow Transplant; 1998 Sep; 22(6):559-64. PubMed ID: 9758343 [Abstract] [Full Text] [Related]
15. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Spinelli S, Chiodi S, Costantini S, Van Lint MT, Raiola AM, Ravera GB, Bacigalupo A. Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313 [Abstract] [Full Text] [Related]
16. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation. Jacobe SJ, Hassan A, Veys P, Mok Q. Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594 [Abstract] [Full Text] [Related]
17. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine. Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S. Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189 [Abstract] [Full Text] [Related]
20. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Schots R, Kaufman L, Van Riet I, Lacor P, Trullemans F, De Waele M, Van Camp B. Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]